Strassburger Philip C. 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Strassburger Philip C.
General Counsel
Transactions
- Award
Common Stock
2023-01-30+55,556→ 115,252 total - Award
Stock Option (Right to Buy)
2023-01-30+166,667→ 166,667 totalExercise: $3.88Exp: 2033-01-29→ Common Stock (166,667 underlying)
Footnotes (3)
- [F1]On January 30, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Includes (i) 105,556 shares of common stock of the Company underlying unvested RSUs (ii) 3,244 shares of the Company's common stock acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan (the "2014 ESPP") on June 30, 2022 and (iii) 4,642 shares of the Company's common stock acquired under the 2014 ESPP on December 31, 2022.
- [F3]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.